Skip to content

Pre- and Postoperative Nutrition in Head and Neck Cancer Patients

A Randomized Controlled Clinical Trial of Pre- and Postoperative Supplementation With Zinc, Vitamin C, Arginine and Multivitamin Mineral in Patients Treated for Head and Neck Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03531190
Enrollment
42
Registered
2018-05-21
Start date
2018-05-10
Completion date
2018-11-30
Last updated
2019-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Keywords

Head and neck cancer, wound healing, pre and post-surgical nutrition, zinc, arginine, vitamin C, protein, oral supplements

Brief summary

The purpose of the project is to investigate the effect of wound healing of a combined pre- and postoperative oral supplement, consisting of zinc, vitamin C, arginine and multivitamin, as a supplement for adequate nutrition in patients operated for head and neck cancer.

Detailed description

The project will be conducted as an open, randomized intervention study, and includes patients with head and neck cancer that are planned for operation. 40 participants are allocated to the intervention or control group, respectively. For both groups, the experiment will last for five to six weeks, depending on when the trial participants are planned for surgery. The intervention group must take a dietary supplement and a protein drink for 35 days (7 days preoperatively and 28 days postoperatively), which is delivered 7 days preoperatively. The same applies to the control group that only receives protein drinks. The length of the intervention period is based on the design of previous studies. During the project, compliance will be evaluated by counting the amount of remaining dietary supplements and protein drinks that the participants return on a regular basis. The control group receives standard treatment as well as protein drinks. For all participants included in the experiment blood tests and an ultrasound scanning will be performed.

Interventions

DIETARY_SUPPLEMENTNutritional supplement (Protein + MIX)

Protein supplement as needed + 750 mg vitamin C, 15 g. arginine, 35 mg. zinc and two multivitamin tablets, by mouth every day for 35 days.

DIETARY_SUPPLEMENTNutritional supplement (Protein)

Protein supplement as needed

Sponsors

Rigshospitalet, Denmark
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized to intervention. Control is the present treatment in the department + protein supplementation

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Authorized/legal age (\> 18 years) * Patients who understand written and oral Danish, and are able to give written consent * Patients diagnosed with head and neck cancer, which are set for surgery * Patients operated on the outside of the neck

Exclusion criteria

* Patients who do not understand, speak or write Danish * Not Authorized/not legal age (\<18 years) * Pregnant and breastfeeding women * Patients previously employed in the field of surgery within the last 5 years (prior years)

Design outcomes

Primary

MeasureTime frameDescription
POSAS-scale (The Patient and Observer Scar Assessment Scale v2.0 / EN)2 monthspoints on POSAS-questionaire (7-70)

Secondary

MeasureTime frameDescription
Appearance of the scar (scale)2 monthsblind professional rating based on rank (from photographs)(1-10)
Ultrasound scanning2 monthsNumber of cavities in the wound
Biochemical measurements (micromol/l) at start and finish2 monthsChanges in the concentrations of micronutrients in the intervention period: p-albumin, p-C-Reactive Protein, p-cobalamin, p-folic acid, p-magnesium, p-ferritin
Size of the scar (cm)2 monthsmeasured with ruler

Other

MeasureTime frameDescription
Peripheral oxygen tension (partial pressure, kPa)2 monthsPeripheral oxygen tension measured on the finger tip
Difficulty in swallowing (scale)2 monthsassessed by rank-scale (1-100)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026